Intra-islet glucagon secretion and action in the regulation of glucose homeostasis

Frontiers in Physiology

Volumn 3 JAN, Issue , 2013, Pages

  Wang, Qinghua ^a,b   Liang, Xinyun ^a,b   Wang, Susanne ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

cells; Cells; Glucagon secretion; Hepatic glucose production; Insulin secretion

Indexed keywords

GLUCAGON; GLUCOSE;

CELL FUNCTION; CELLULAR SECRETION; DIABETES MELLITUS; DISEASE ASSOCIATION; GLUCAGON RELEASE; GLUCOSE HOMEOSTASIS; GLYCOGEN SYNTHESIS; GLYCOLYSIS; HORMONAL REGULATION; HORMONE RESPONSE; HUMAN; INSULIN LIKE ACTIVITY; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS REGULATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84874675433     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00485     Document Type: Review

References (74)

1. Banarer, S., McGregor, V. P., and Cryer, P. E. (2002). Intraislet hyper-insulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. Diabetes 51, 958-965.
2. Bancila, V., Cens, T., Monnier, D., Chanson, F., Faure, C., Dunant, Y., et al. (2005). Two SUR1-specific histidine residues mandatory for zinc-induced activation of the rat KATP channel. J. Biol. Chem. 280, 8793-8799.
3. Bansal, P., and Wang, Q. (2008). Insulin as a physiological modulator of glucagon secretion. Am.J.Physiol. Endocrinol. Metab. 295, E751-E761.
4. Bansal, P., Wang, S., Liu, S., Xiang, Y. Y., Lu, W. Y., and Wang, Q. (2011). GABA coordinates with insulin in regulating secretory function in pancreatic INS-1 beta-cells. PLoS ONE 6:e26225. doi: 10.1371/jour-nal.pone.0026225
5. Barg, S., Galvanovskis, J., Gopel, S. O., Rorsman, P., and Eliasson, L. (2000). Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells. Diabetes 49, 1500-1510.
6. Bevan, P. (2001). Insulin signalling. J. Cell Sci. 114, 1429-1430.
7. Blazquez, E., Munoz-Barragan, L., Patton, G. S., Orci, L., Dobbs, R. E., and Unger, R. H. (1976). Gastric A-cell function in insulin-deprived depancreatized dogs. Endocrinology 99, 1182-1188.
8. Bolli, G. B. (1998). Counterregulatory mechanisms to insulin-induced hypoglycemia in humans: rele-vance to the problem of intensive treatment of IDDM. J. Pediatr. Endocrinol. Metab. 11(Suppl. 1), 103-115.
9. Bonner-Weir, S., and Orci, L. (1982). New perspectives on the microvas-culature of the islets of Langerhans in the rat. Diabetes 31, 883-889.
10. Bosco, D., Armanet, M., Morel, P., Niclauss, N., Sgroi, A., Muller, Y. D., et al. (2010). Unique arrangement of alpha-and beta-cells in human islets of Langerhans. Diabetes 59, 1202-1210.
11. Braaten, J. T., Faloona, G. R., and Unger, R. H. (1974). The effect of insulin on the alpha-cell response to hyperglycemia in long-standing alloxan diabetes. J. Clin. Invest. 53, 1017-1021.
12. Braun, M., Ramracheya, R., Bengtsson, M., Clark, A., Walker, J. N., Johnson, P. R., et al. (2010). Gamma-aminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic beta-cells. Diabetes 59, 1694-1701.
13. Burcelin, R., Li, J., and Charron, M. J. (1995). Cloning and sequence analysis of the murine glucagon receptor-encoding gene. Gene 164, 305-310.
14. Cabrera, O., Berman, D. M., Kenyon, N. S., Ricordi, C., Berggren, P. O., and Caicedo, A. (2006). The unique cytoarchitecture of human pancre-atic islets has implications for islet cell function. Proc. Natl. Acad. Sci. U.S.A. 103, 2334-2339.
15. Cabrera, O., Jacques-Silva, M. C., Speier,S.,Yang,S.N.,Kohler, M., Fachado, A., et al. (2008). Glutamate is a positive autocrine signal for glucagon release. Cell Metab. 7, 545-554.
16. Carstens, S., and Andersen, I. (1994). [Intranasal glucagon in the treat-ment of hypoglycemia. A therapeu-tic possibility in the future]. Ugeskr. Laeger 156, 4339-4342.
17. Cejvan, K., Coy, D. H., and Efendic, S. (2003). Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats. Diabetes 52, 1176-1181.
18. Chen, L., Komiya, I., Inman, L., O'Neil, J., Appel, M., Alam, T., et al. (1989). Effects of hypoglycemia and prolonged fasting on insulin and glucagon gene expression. Studies with in situ hybridization. J. Clin. Invest. 84, 711-714.
19. Cooperberg, B. A., and Cryer, P. E. (2009). Beta-cell-mediated signal-ing predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans. Diabetes Care 32, 2275-2280.
20. Cooperberg, B. A., and Cryer, P. E. (2010). Insulin reciprocally regu-lates glucagon secretion in humans. Diabetes 59, 2936-2940.
21. Cryer, P. E. (2007). Hypoglycemia, functional brain failure, and brain death. J. Clin. Invest. 117, 868-870.
22. Cryer,P.E.,Davis,S.N.,andShamoon, H. (2003). Hypoglycemia in dia-betes. Diabetes Care 26, 1902-1912.
23. Hauge-Evans, A. C., King, A. J., Carmignac, D., Richardson, C. C., Robinson, I. C., Low, M. J., et al. (2009). Somatostatin secreted by islet delta-cells fulfills multi-ple roles as a paracrine regulator of islet function. Diabetes 58, 403-411.
24. Haymond, M. W., and Schreiner, B. (2001). Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes. Diabetes Care 24, 643-645.
25. Huypens, P., Ling, Z., Pipeleers, D., and Schuit, F. (2000). Glucagon receptors on human islet cells contribute to glucose competence of insulin release. Diabetologia 43, 1012-1019.
26. Hvidberg, A., Djurup, R., and Hilsted, J. (1994). Glucose recovery after intranasal glucagon during hypo-glycaemia in man. Eur. J. Clin. Pharmacol. 46, 15-17.
27. Jiang, G., and Zhang, B. B. (2003). Glucagon and regulation of glucose metabolism. Am. J. Physiol. Endocrinol. Metab. 284, E671-E678.
28. Kanno, T., Gopel, S. O., Rorsman, P., and Wakui, M. (2002). Cellular function in multicellular system for hormone-secretion: electro-physiological aspect of studies on alpha-, beta-and delta-cells of the pancreatic islet. Neurosci. Res. 42, 79-90.
29. Kawai, K., Yokota, C., Ohashi, S., Watanabe, Y., and Yamashita, K. (1995). Evidence that glucagon stimulates insulin secretion through its own receptor in rats. Diabetologia 38, 274-276.
30. Kawamori,D.,Kurpad,A.J.,Hu,J., Liew,C.W.,Shih,J.L.,Ford,E. L., et al. (2009). Insulin signaling in alpha cells modulates glucagon secretion in vivo. Cell Metab. 9, 350-361.
31. Kedia, N. (2011). Treatment of severe diabetic hypoglycemia with glucagon: an underutilized thera-peutic approach. Diabetes Metab. Syndr. Obes. 4, 337-346.
32. Larsson, H., and Ahren, B. (2000). Islet dysfunction in insulin resis-tance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance. Diabetes Care 23, 650-657.
33. Lee, Y., Berglund, E. D., Wang, M. Y.,Fu,X.,Yu,X.,Charron,M. J., et al. (2012). Metabolic mani-festations of insulin deficiency do not occur without glucagon action. Proc. Natl. Acad. Sci. U.S.A. 109, 14972-14976.
34. Lee, Y., Wang, M. Y., Du, X. Q., Charron, M. J., and Unger, R. H. (2011). Glucagon receptor knock-out prevents insulin-deficient type 1 diabetes in mice. Diabetes 60, 391-397.
35. Lefebvre, P. J. (1995). Glucagon and its family revisited. Diabetes Care 18, 715-730.
36. Leung, Y. M., Ahmed, I., Sheu, L., Tsushima, R. G., Diamant, N. E., Hara, M., et al. (2005). Electrophysiological character-ization of pancreatic islet cells in the mouse insulin promoter-green fluorescent protein mouse. Endocrinology 146, 4766-4775.
37. Li,X.C.,Liao,T.D.,and Zhuo,J. L. (2008). Long-term hyperglucago-naemia induces early metabolic and renal phenotypes of Type 2 dia-betes in mice. Clin.Sci.(Lond.)114, 591-601.
38. Liang, Y., Osborne, M. C., Monia, B. P., Bhanot, S., Gaarde, W. A., Reed, C., et al. (2004). Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice. Diabetes 53, 410-417.
39. Lins, P. E., Wajngot, A., Adamson, U., Vranic, M., and Efendic, S. (1983). Minimal increases in glucagon lev-els enhance glucose production in man with partial hypoinsulinemia. Diabetes 32, 633-636.
40. Liu,Z.,Kim,W.,Chen,Z.,Shin,Y. K.,Carlson,O.D.,Fiori,J.L.,etal. (2011). Insulin and glucagon reg-ulate pancreatic alpha-cell prolif-eration. PLoS ONE 6:e16096. doi: 10.1371/journal.pone.0016096
41. MacDonald, P. E., De Marinis, Y. Z., Ramracheya, R., Salehi, A., Ma, X., Johnson, P. R., et al. (2007). A K ATP channel-dependent path-way within alpha cells regulates glucagon release from both rodent and human islets of Langerhans. PLoS Biol. 5:e143. doi: 10.1371/jour-nal.pbio.0050143
42. Maharaj, A., Zhu, L., Huang, F., Qiu, H.,Li,H.,Zhang,C.Y.,etal. (2012). Ectopic expression of glucagon receptor in skeletal mus-cles improves glucose homeostasis in a mouse model of diabetes. Diabetologia 55, 1458-1468.
43. Marchetti, P., Lupi, R., Bugliani, M., Kirkpatrick, C. L., Sebastiani, G., Grieco, F. A., et al. (2012). A local glucagon-like peptide 1 (GLP-1)systeminhumanpan-creatic islets. Diabetologia 55, 3262-3272.
44. Maruyama, H., Hisatomi, A., Orci, L., Grodsky, G. M., and Unger, R. H. (1984). Insulin within islets is a physiologic glucagon release inhibitor. J. Clin. Invest. 74, 2296-2299.
45. Matsuda, M., Defronzo, R. A., Glass, L.,Consoli,A.,Giordano,M., Bressler, P., et al. (2002). Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals. Metabolism 51, 1111-1119.
46. McKinnon, C. M., Ravier, M. A., and Rutter, G. A. (2006). FoxO1 is required for the regulation of preproglucagon gene expres-sion by insulin in pancreatic alphaTC1-9 cells. J. Biol. Chem. 281, 39358-39369.
47. Myers,S.R.,Diamond,M.P.,Adkins-Marshall, B. A., Williams, P. E., Stinsen, R., and Cherrington, A. D. (1991). Effects of small changes in glucagon on glucose produc-tion during a euglycemic, hyper-insulinemic clamp. Metabolism 40, 66-71.
48. Petersen, K. F., and Sullivan, J. T. (2001). Effects of a novel glucagon receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans. Diabetologia 44, 2018-2024.
49. Philippe, J. (1989). Glucagon gene transcription is negatively reg-ulated by insulin in a hamster islet cell line. J. Clin. Invest. 84, 672-677.
50. Philippe, J., Morel, C., and Cordier-Bussat, M. (1995). Islet-specific proteins interact with the insulin-response element of the glucagon gene. J. Biol. Chem. 270, 3039-3045.
51. Raskin, P., Aydin, I., and Unger, R. H. (1976). Effect of insulin on the exag-gerated glucagon response to argi-nine stimulation in diabetes melli-tus. Diabetes 25, 227-229.
52. Raskin,P.,Fujita,Y.,and Unger,R.H. (1975). Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics. J. Clin. Invest. 56, 1132-1138.
53. Rizza, R., Verdonk, C., Miles, J., Service, F. J., and Gerich, J. (1979). Effect of intermittent endogenous hyper-glucagonemia on glucose home-ostasis in normal and diabetic man. J. Clin. Invest. 63, 1119-1123.
54. Rouille, Y., Kantengwa, S., Irminger, J. C., and Halban, P. A. (1997). Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1. J. Biol. Chem. 272, 32810-32816.
55. Salehi, A., Dornonville de la Cour, C., Hakanson, R., and Lundquist, I. (2004). Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice. Regul. Pept. 118, 143-150.
56. Schinner, S., Barthel, A., Dellas, C., Grzeskowiak, R., Sharma, S. K., Oetjen, E., et al. (2005). Protein kinase B activity is sufficient to mimic the effect of insulin on glucagon gene transcription. J. Biol. Chem. 280, 7369-7376.
57. Shah, P., Vella, A., Basu, A., Basu, R.,Schwenk,W.F.,and Rizza, R. A. (2000). Lack of suppres-sion of glucagon contributes to postprandial hyperglycemia in sub-jects with type 2 diabetes melli-tus. J. Clin. Endocrinol. Metab. 85, 4053-4059.
58. Sherwin, R. S., Fisher, M., Hendler, R., and Felig, P. (1976). Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects. N. Engl. J. Med. 294, 455-461.
59. Soltani, N., Qiu, H., Aleksic, M., Glinka, Y., Zhao, F., Liu, R., et al. (2011). GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes. Proc. Natl. Acad. Sci. U.S.A. 108, 11692-11697.
60. Sorensen, H., Winzell, M. S., Brand, C. L., Fosgerau, K., Gelling, R. W., Nishimura, E., et al. (2006). Glucagon receptor knockout mice display increased insulin sensitiv-ity and impaired beta-cell function. Diabetes 55, 3463-3469.
61. Stagner, J. I., and Samols, E. (1992). The vascular order of islet cellular perfusion in the human pancreas. Diabetes 41, 93-97.
62. Stagner, J. I., Samols, E., and Bonner-Weir, S. (1988). beta-alpha-delta pancreatic islet cellular per-fusion in dogs. Diabetes 37, 1715-1721.
63. Stutzer, I., Esterhazy, D., and Stoffel, M. (2012). The pancreatic beta cell surface proteome. Diabetologia 55, 1877-1889.
64. Tsuchiyama, N., Takamura, T., Ando, H., Sakurai, M., Shimizu, A., Kato, K., et al. (2007). Possible role of alpha-cell insulin resis-tance in exaggerated glucagon responses to arginine in type 2 diabetes. Diabetes Care 30, 2583-2587.
65. Uehara, S., Muroyama, A., Echigo, N., Morimoto, R., Otsuka, M., Yatsushiro, S., et al. (2004). Metabotropic glutamate receptor type 4 is involved in autoinhibitory cascade for glucagon secretion by alpha-cells of islet of Langerhans. Diabetes 53, 998-1006.
66. Unger, R. H. (1978). Role of glucagon in the pathogenesis of diabetes: the status of the ontroversy. Metab. Clin. Exp. 27, 1691-1709.
67. Unger, R. H. (1985). Glucagon phys-iology and pathophysiology in the light of new advances. Diabetologia 28, 574-578.
68. Unger, R. H., and Orci, L. (2010). Paracrinology of islets and the paracrinopathy of diabetes. Proc. Natl. Acad. Sci. U.S.A. 107, 16009-16012.
69. Vuguin,P.M.,Kedees,M.H.,Cui,L., Guz,Y.,Gelling,R.W.,Nejathaim, M., et al. (2006). Ablation of the glucagon receptor gene increases fetal lethality and produces alter-ations in islet development and maturation. Endocrinology 147, 3995-4006.
70. Xu, E., Kumar, M., Zhang, Y., Ju, W., Obata, T., Zhang, N., et al. (2006). Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system. Cell Metab. 3, 47-58.
71. Yan,H.,Gu,W.,Yang,J.,Bi,V.,Shen, Y., Lee, E., et al. (2009). Fully human monoclonal antibodies antagonizing the glucagon receptor improve glucose home-ostasis in mice and monkeys. J. Pharmacol. Exp. Ther. 329, 102-111.
72. Young, A. A., Cooper, G. J., Carlo, P., Rink, T. J., and Wang, M. W. (1993). Response to intra-glycemic rats. Am. J. Physiol. 264, E943-E950.
73. Zhang, Y., Zhang, N., Gyulkhandanyan, A.V.,Xu,E.,Gaisano,H. Y., Wheeler, M. B., et al. (2008). Presence of functional hyperpolarisation-activated cyclic nucleotide-gated channels in clonal alpha cell lines and rat islet alpha cells. Diabetologia 51, 2290-2298.
74. Zhou, H., Zhang, T., Harmon, J. S., Bryan, J., and Robertson, R. P. (2007). Zinc, not insulin, regu-lates the rat alpha-cell response to hypoglycemia in vivo. Diabetes 56, 1107-1112.